You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海南海藥(000566.SZ):控股子公司江蘇普健擬增資擴股 持股降至56.41%
格隆匯 04-13 21:40

格隆匯4月13日丨海南海藥(000566.SZ)公佈,公司控股子公司江蘇普健藥業有限公司(“江蘇普健”)擬增資擴股,濱海醫藥產業園開發有限公司(“濱海醫藥”)擬以現金3000萬元增資江蘇普健,其中667.84萬元計入江蘇普健註冊資本,其餘2332.16萬元計入資本公積。增資完成後,濱海醫藥持有江蘇普健5.98%的股權,公司、濱海醫藥和江蘇普健其他股東各方擬簽署《江蘇普健藥業有限公司增資合同》,公司放棄江蘇普健優先認繳出資權。

此次增資完成後,海南海藥合計持有江蘇普健的股權比例將由60%降至56.41%,江蘇普健仍為海南海藥的控股子公司;濱海醫藥持有江蘇普健5.98%的股權。

江蘇普健藥業有限公司經營範圍:藥品生產(除危險化學品),藥品技術研發及其技術轉讓。(依法須經批准的項目,經相關部門批准後方可開展經營活動)

為優化股權結構,發揮各方資源優勢,構建鹽城醫藥化工全產業鏈平台,公司與江蘇省鹽城市濱海縣政府一起整合濱海醫藥產業園優勢企業,強強聯合,打造鹽城市乃至江蘇省有影響力的“中間體-原料藥-製劑”全產業示範基地。此次公司放棄優先認購權和江蘇普健增資完成後,海南海藥合計持有江蘇普健的股權比例將由60%降至56.41%,江蘇普健仍為海南海藥的控股子公司。此次放棄權利不會影響公司合併報表範圍,不會對公司未來持續經營能力產生不利影響。

公司及控股子公司重慶天地藥業有限責任公司如不放棄優先認購權且維持原持股比例所需出資的最高金額為1800萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account